For following the competition: what moved in each program, several studies read as one move.
- nerandomilast
- ULSC
- Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F
- + 27 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Myositis to watchlistEvery Monday by email · turn it off any timePro · free during the beta